Build your base

Alienum phaedrum torquatos nec eu, vis detraxit periculis ex, nihil expetendis in mei. Mei an pericula euripidis, hinc partem ei est.
Back to top

Maryna Kolochavina, PharmD, PhD, PMP

New Horizon / Maryna Kolochavina, PharmD, PhD, PMP
Maryna Kolochavina

Maryna Kolochavina, PharmD, PhD, PMP

Director, Five Voices Consortium


Dr. Maryna Kolochavina, PharmD, PhD, PMP. Executive leader and trusted advisor with 18 years of experience in a lifecycle asset management of over 242 rare and orphan medicinal products and advanced therapies in 42 therapeutic classes with 440 orphan drug designations, resulting in approximately $3.2bn in capital committed to alliances with biotechnology and pharmaceutical partners of all sizes. Active patient advocate for people with rare and orphan condition, representing a Patient Voice initiative in Charité, Berlin, Germany. Clinical pharmacology background with translational PhD on rare skin diseases. Member of 14 organisations, 1 board of directors